Ziprasidone monotherapy in bipolar II depression: An open trial

Abstract Background The use of atypical neuroleptics for bipolar depression is currently being studied extensively. Given ziprasidone's favorable side effect profile as compared to other atypical neuroleptics, and the dearth of studies of this drug in depressed bipolar patients, we initiated an...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of affective disorders 2009-11, Vol.118 (1), p.205-208
Hauptverfasser:	Liebowitz, Michael R, Salmán, Ester, Mech, Arnold, Dunner, David, Johnson, Ann E, Akhtar, Jamil, Pratap, Rajiv
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Adult and adolescent clinical studies Affect - drug effects Antipsychotic Agents - adverse effects Antipsychotic Agents - therapeutic use Antipsychotic drugs Biological and medical sciences Bipolar affective disorder Bipolar Disorder - diagnosis Bipolar Disorder - drug therapy Bipolar Disorder - psychology Bipolar disorders Bipolar II Depression Depressive Disorder, Major - diagnosis Depressive Disorder, Major - drug therapy Depressive Disorder, Major - psychology Dose-Response Relationship, Drug Female Humans Informed consent Interview, Psychological Major depression Male Medical sciences Middle Aged Mood disorders Neuropharmacology Personality Inventory - statistics & numerical data Pharmacology. Drug treatments Piperazines - adverse effects Piperazines - therapeutic use Psychiatry Psycholeptics: tranquillizer, neuroleptic Psychology. Psychoanalysis. Psychiatry Psychometrics Psychopathology. Psychiatry Psychopharmacology Side effects Suffering Thiazoles - adverse effects Thiazoles - therapeutic use Treatment Outcome Ziprasidone
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!